Whilst an association between smoking and CDKN2A inactivation has not previously been identified in OSCC, a meta-analysis in non-small cell lung carcinoma (NSCLC) has reported a positive association between p16 promoter methylation and smoking [55]. The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.